All cystic fibrosis articles
-
NewsAiming for more targeted treatment of serious lung infections
Microbial experts are using DNA sequencing readings to provide more accurate identification of microbial infections, which helps to address risks from long-term use of antibiotics in cystic fibrosis patients.
-
NewsBiofilm clue opens route to anti-infection treatments of the future
A multidisciplinary study has uncovered a critical component in the formation of biofilms, the complex structures used by bacteria to colonise surfaces. The research may have implications for future infection treatments, including for people with cystic fibrosis.
-
NewsPartners in crime produce extreme antibiotic resistance
A study shows how environmental bacteria enter the lungs during an infection and transfer antibiotic resistance genes to disease-causing bacteria.
-
NewsStudy reveals how bacteria assemble their envelope
Researchers have discovered a key process for how the outer membrane of gram-negative bacteria attaches to the cell wall, advancing the understanding of how these bacteria frequently manifest resistance to antibiotics.
-
NewsResearchers deploy phage therapy in new frontier against antimicrobial resistant infectious diseases
A revelatory treatment for patients with life-threatening infectious diseases is being pioneered in Melbourne. VICPhage, a clinical partnership between The Alfred and Monash, is one of the first in Australia to offer end-to-end capacity in phage therapy to treat some of the most challenging infections.
-
NewsResearchers disable antimicrobial resistance in cystic fibrosis-associated bacteria
A newly discovered mechanism renders antibiotic-resistant bacteria vulnerable by disabling both their individual resistance and a process known as cross-protection, the ability of resistant bacteria to shield nearby, otherwise sensitive strains.
-
NewsCDI breakthroughs lead to new drug development deal for deadly NTM bacteria
Scientists have developed new compounds against non-tuberculous mycobacteria which are now the subject of a new collaboration and license agreement with the Switzerland-based and publicly listed BioVersys AG.
-
NewsLiquorice root could be effective against upper respiratory tract infections - while protecting ‘good’ microbes
Lozenges supplemented with liquorice root extract could be an effective remedy against upper respiratory tract infections while protecting microbes that are beneficial to the body, reveals a study presented at MLS Future Forum, which is supported by Applied Microbiology International.
-
NewsSpotlight on phage for a fascinating policy discussion
Scientists turned the spotlight onto the potential of phage in a recent AMI webinar that yielded a fascinating in-depth discussion that proved invaluable in clarifying the way forward. The ‘Phages for a Sustainable Future’ webinar has now been released as a video.
-
NewsScientists home in for a close look at lung infections
A new study has meticulously sampled different lung regions in people with cystic fibrosis to understand why infections persist after new treatments.
-
NewsPandora’s microbes – The battle for iron in the lungs
Newly discovered natural compounds from the little studied Pandoraea bacterium influence the lung microbiome by competing for iron.
-
NewsGlobal phage experts converge in Berlin to shape the future of antimicrobial medicine
The 8th World Congress on Targeting Phage Therapy (June 10–11, 2025) returns to Berlin, bringing together over 75 international speakers and contributors from 27 countries.
-
NewsYeast produces human DNase1 for the first time
The protein DNase1 is used to treat cystic fibrosis but it takes considerable effort and cost to produce it in immortalized hamster cells. Researchers have now produced it in yeast cells for the first time.
-
NewsStalled microbiomes: cystic fibrosis disrupts early gut development in infants
A new study highlights key differences in the gut microbiome (communities of bacteria) of infants with cystic fibrosis (CF) compared to that of healthy infants, and how these alterations may adversely affect their health.
-
FeaturesBridging the gap: mouse breath research to advance infectious disease diagnostics
The role of VOCs in health and disease is garnering increasing attention, particularly in their use as biomarkers for a wide range of medical conditions.
-
NewsBacteria in polymers form cables that grow into living gels
Scientists have discovered that bacterial cells growing in a solution of polymers, such as mucus, form long cables that buckle and twist on each other, building a kind of “living Jell-O.”
-
News$7 Million grant to tackle lung infections through innovative probiotic treatment
The PROTECT project seeks to combat lung infections by assembling a community of beneficial lung microbes that can outcompete harmful pathogens.
-
NewsRespiratory bacteria ‘turns off’ immune system to survive
Researchers have identified how a common bacterium is able to manipulate the human immune system during respiratory infections and cause persistent illness.
-
NewsScientists map how deadly bacteria evolved to become epidemic
Pseudomonas aeruginosa evolved rapidly and then spread globally over the last 200 years, probably driven by changes in human behaviour, a new study has found.
-
NewsStudy provides new insights into phage therapy design
Results from a new study are providing new insights into the therapeutic potential of bacteriophage (phage) therapy for treating diseases like cystic fibrosis (CF).